
To help keep our community authentic, we're showing information about accounts on Linktree.
Nisticò Lab has been a member of Linktree for 1 month and joined in June 2026. The social media accounts linked to from Nisticò Lab are: • LinkedIn • X Besides social media accounts, NisticoLab has populated their site with: • NisticoLab · X (Twitter) • pubmed.ncbi.nlm.nih.gov • Challenges and advances in drug resistance and tolerance in cancer | Journal of Experimental & Clinical Cancer Research | Springer Nature Link • UOSD Immunology and Immunotherapy – Ricerca IFO • Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC • Tertiary lymphoid structures in the era of cancer therapy | Journal of Experimental & Clinical Cancer Research | Springer Nature Link • Google Scholar - Paola Nisticò • Chapter Fourteen - Optimized phospho-flow cytometry for quantitative analysis of early TCR-proximal signaling: Implications for T cell function in onco-immunology • Chapter Ten - Methodological advances to analyze cancer-associated fibroblast-derived ECM effects on macrophage polarization • Chapter Nine - Phenotypic characterization and function of tumor infiltrating and peripheral B cells in cancer patients • Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC • Highlighting recent achievements to advance more effective cancer immunotherapy | Journal of Experimental & Clinical Cancer Research | Springer Nature Link • AI drives the assessment of lung cancer microenvironment composition • Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC